Showing 381 - 400 results of 425 for search '"liver transplantation"', query time: 0.07s Refine Results
  1. 381
  2. 382

    Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study by Jung Hee Kim, Sung-Eun Kim, Do Seon Song, Hee Yeon Kim, Eileen L. Yoon, Ji Won Park, Tae Hyung Kim, Young-Kul Jung, Ki Tae Suk, Hyung Joon Yim, Jung Hyun Kwon, Sung Won Lee, Seong Hee Kang, Moon Young Kim, Soung Won Jeong, Jae-Young Jang, Jeong Ju Yoo, Sang Gyune Kim, Young-Joo Jin, Gab Jin Cheon, Byung Seok Kim, Yeon Seok Seo, Hyoungsu Kim, Dong Hyun Sinn, Woo Jin Chung, Hwi Young Kim, Han Ah Lee, Seung Woo Nam, In Hee Kim, Ji Hoon Kim, Hee Bok Chae, Joo Hyun Sohn, Ju Yeon Cho, Yoon Jun Kim, Jin Mo Yang, Jung Gil Park, Won Kim, Hyun Chin Cho, Dong Joon Kim

    Published 2025-12-01
    “…Viral hepatitis with alcohol-related CLD showed a poor liver function profile and a high frequency of acute-on-chronic liver failure (ACLF) [22.1% vs. 19.6% (alcohol CLD), 8.1% (viral CLD), 5.6% (autoimmune related CLD and 16.0% (cryptogenic CLD)] with worse adverse outcomes (mortality or liver transplantation) than other aetiologies. The difference in aetiology was a significant factor for 28-day adverse outcomes in multivariate analysis even in a high MELD score (≥15), which indicated poor baseline liver function and prognosis (p < 0.001).Conclusion The aetiology of CLD constitutes a pivotal determinant influencing both short- and long-term adverse outcomes of AD in CLD, even among individuals presenting with elevated MELD scores. …”
    Get full text
    Article
  3. 383
  4. 384

    Contextual Vulnerability Should Guide Fair Subject Selection in Xenotransplantation Clinical Trials by Gianna Strand

    Published 2023-03-01
    “…[xvii] Large cohort studies of both pediatric kidney and liver transplant recipients found no correlation between intellectual disability and graft or patient survival.…”
    Get full text
    Article
  5. 385
  6. 386
  7. 387

    Primary Hepatic Neuroendocrine Tumor with Unusual Thyroid Follicular-Like Morphologic Characteristics by Mohd Elmugtaba Ibrahim, Kerolos Abadeer, Qihui (Jim) Zhai, Aziza Nassar

    Published 2017-01-01
    “…In 2008, the patient’s liver transplant failed because of ischemic cholangiopathy, and she underwent a second liver transplant. …”
    Get full text
    Article
  8. 388

    The Relationship Between Hepatopulmonary Syndrome and Altitude by Morgan A Valley, James F Trotter, Deborah Thomas, Adit A Ginde, Steven R Lowenstein, Benjamin Honigman

    Published 2014-01-01
    “…BACKGROUND: In a previous small retrospective study, the authors reported that hepatopulmonary syndrome was less common among liver transplant candidates at high-altitude centres compared with low-altitude centres.…”
    Get full text
    Article
  9. 389

    Chronic Hepatitis C with Cyanosis by Mahmood Alawainati, Jawad Khamis, Muneer Abdulla, Saeed Alsaeed

    Published 2019-01-01
    “…Screening for this complication is appropriate in liver transplant candidates, and diagnosed patients should be evaluated extensively for liver transplant.…”
    Get full text
    Article
  10. 390

    Improving 1-year liver allograft survival hazard ratios by Resham­ Ramkissoon, Ashley Rosier, Savitha Iyengar, Timucin Taner, William Sanchez

    Published 2025-01-01
    “…Our balance measure was maintaining similar liver transplant volumes and avoiding limiting access to transplant. …”
    Get full text
    Article
  11. 391

    Posttransplant Metabolic Syndrome by M. Shadab Siddiqui, Richard K. Sterling

    Published 2012-01-01
    “…Until then, early recognition, prevention, and treatment of its components are vital in improving outcomes in liver transplant recipients.…”
    Get full text
    Article
  12. 392

    A Practical Review of Cytomegalovirus in Gastroenterology and Hepatology by Ali Y. Fakhreddine, Catherine T. Frenette, Gauree G. Konijeti

    Published 2019-01-01
    “…This review will focus on the pathophysiology, diagnosis, and management of CMV in patient populations relevant to the practice of gastroenterology and hepatology—liver transplant recipients, inflammatory bowel disease patients, and otherwise immunocompetent patients.…”
    Get full text
    Article
  13. 393

    Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin by Morris Sherman, Lawrence Cohen, Mary Anne Cooper, Magdy Elkashab, Victor Feinman, David Fletcher, Nigel Girgrah, Jenny Heathcote, Mark Levstik, William B McNaull, David Wong, Florence Wong, Colina Yim

    Published 2006-01-01
    “…Data also support the clinical benefit of combination antiviral therapy in patients coinfected with HCV and HIV, and in patients who have received a liver transplant.…”
    Get full text
    Article
  14. 394

    Nontoxigenic Vibrio cholerae Septicemia in an Immunocompromised Patient by Kamran Kadkhoda, Heather Adam, Matthew W. Gilmour, Gregory W. Hammond

    Published 2012-01-01
    “…We report a recent case of non-O1, non-O139, nontoxigenic Vibrio cholerae septicemia in a post-liver-transplant immunocompromised patient associated with prior seafood consumption. …”
    Get full text
    Article
  15. 395

    Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide by Iuliana Vaxman, John Eaton, Hee Eun Lee, Morie A. Gertz

    Published 2020-01-01
    “…Herein we present a patient that underwent a liver transplant due to primary biliary cholangitis (PBC) and after 9 years developed multiple myeloma. …”
    Get full text
    Article
  16. 396
  17. 397

    Acute Fatty Liver Disease of Pregnancy in the Second Trimester by Faraz Afridi, Michael Feely, Raju Reddy

    Published 2020-01-01
    “…She was diagnosed with AFLP as per the Swansea criteria. An orthotopic liver transplant was attempted but was unsuccessful. AFLP usually presents between the 30th to 38th weeks of gestation. …”
    Get full text
    Article
  18. 398

    Pharmacometabolomics Enables Real-World Drug Metabolism Sciences by Fleur B. Nijdam, Marieke A. J. Hof, Hans Blokzijl, Stephan J. L. Bakker, Eelko Hak, Gérard Hopfgartner, Frank Klont, on behalf of the TransplantLines Investigators

    Published 2025-01-01
    “…Lastly, the observed metabolic patterns showed no notable differences between kidney and liver transplant recipients. <b>Conclusions</b>: Our findings demonstrate the potential of PMx to enhance the understanding of drug metabolism, even for well-studied compounds such as CsA. …”
    Get full text
    Article
  19. 399

    The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review by Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar

    Published 2021-01-01
    “…Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that can lead to end-stage liver disease needing a liver transplant. Many pharmacological approaches are used to reduce the disease progression in NAFLD. …”
    Get full text
    Article
  20. 400